Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Anti-Infective Drugs Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 OTC
  • 1.3.3 Rx Drugs
• 1.4 Market Segment by Application
  • 1.4.1 Global Anti-Infective Drugs Market Share by Application (2019-2025)
  • 1.4.2 Hospital
  • 1.4.3 Drugs Store
  • 1.4.4 Other
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Anti-Infective Drugs Market Size
  • 2.1.1 Global Anti-Infective Drugs Revenue 2014-2025
  • 2.1.2 Global Anti-Infective Drugs Sales 2014-2025
• 2.2 Anti-Infective Drugs Growth Rate by Regions
  • 2.2.1 Global Anti-Infective Drugs Sales by Regions 2014-2019
  • 2.2.2 Global Anti-Infective Drugs Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Anti-Infective Drugs Sales by Manufacturers
  • 3.1.1 Anti-Infective Drugs Sales by Manufacturers 2014-2019
  • 3.1.2 Anti-Infective Drugs Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Anti-Infective Drugs Revenue by Manufacturers (2014-2019)
  • 3.2.2 Anti-Infective Drugs Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Anti-Infective Drugs Market Concentration Ratio (CR5 and HHI)
• 3.3 Anti-Infective Drugs Price by Manufacturers
• 3.4 Key Manufacturers Anti-Infective Drugs Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Anti-Infective Drugs Market
• 3.6 Key Manufacturers Anti-Infective Drugs Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 OTC Sales and Revenue (2014-2019)
  • 4.1.2 Rx Drugs Sales and Revenue (2014-2019)
• 4.2 Global Anti-Infective Drugs Sales Market Share by Type
• 4.3 Global Anti-Infective Drugs Revenue Market Share by Type
• 4.4 Anti-Infective Drugs Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Anti-Infective Drugs Sales by Application

6 United States

• 6.1 United States Anti-Infective Drugs Breakdown Data by Company
• 6.2 United States Anti-Infective Drugs Breakdown Data by Type
• 6.3 United States Anti-Infective Drugs Breakdown Data by Application

7 European Union

• 7.1 European Union Anti-Infective Drugs Breakdown Data by Company
• 7.2 European Union Anti-Infective Drugs Breakdown Data by Type
• 7.3 European Union Anti-Infective Drugs Breakdown Data by Application

8 China

• 8.1 China Anti-Infective Drugs Breakdown Data by Company
• 8.2 China Anti-Infective Drugs Breakdown Data by Type
• 8.3 China Anti-Infective Drugs Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Anti-Infective Drugs Breakdown Data by Company
• 9.2 Rest of World Anti-Infective Drugs Breakdown Data by Type
• 9.3 Rest of World Anti-Infective Drugs Breakdown Data by Application
• 9.4 Rest of World Anti-Infective Drugs Breakdown Data by Countries
  • 9.4.1 Rest of World Anti-Infective Drugs Sales by Countries
  • 9.4.2 Rest of World Anti-Infective Drugs Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 GlaxoSmithKline
  • 10.1.1 GlaxoSmithKline Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Anti-Infective Drugs
  • 10.1.4 Anti-Infective Drugs Product Introduction
  • 10.1.5 GlaxoSmithKline Recent Development
• 10.2 Merck
  • 10.2.1 Merck Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Anti-Infective Drugs
  • 10.2.4 Anti-Infective Drugs Product Introduction
  • 10.2.5 Merck Recent Development
• 10.3 Pfizer
  • 10.3.1 Pfizer Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Anti-Infective Drugs
  • 10.3.4 Anti-Infective Drugs Product Introduction
  • 10.3.5 Pfizer Recent Development
• 10.4 Novartis AG
  • 10.4.1 Novartis AG Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Anti-Infective Drugs
  • 10.4.4 Anti-Infective Drugs Product Introduction
  • 10.4.5 Novartis AG Recent Development
• 10.5 Gilead Sciences
  • 10.5.1 Gilead Sciences Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Anti-Infective Drugs
  • 10.5.4 Anti-Infective Drugs Product Introduction
  • 10.5.5 Gilead Sciences Recent Development
• 10.6 Abbott
  • 10.6.1 Abbott Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Anti-Infective Drugs
  • 10.6.4 Anti-Infective Drugs Product Introduction
  • 10.6.5 Abbott Recent Development
• 10.7 Wyeth
  • 10.7.1 Wyeth Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Anti-Infective Drugs
  • 10.7.4 Anti-Infective Drugs Product Introduction
  • 10.7.5 Wyeth Recent Development
• 10.8 Sanofi-Aventis
  • 10.8.1 Sanofi-Aventis Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Anti-Infective Drugs
  • 10.8.4 Anti-Infective Drugs Product Introduction
  • 10.8.5 Sanofi-Aventis Recent Development
• 10.9 Bristol-Myers Squibb
  • 10.9.1 Bristol-Myers Squibb Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Anti-Infective Drugs
  • 10.9.4 Anti-Infective Drugs Product Introduction
  • 10.9.5 Bristol-Myers Squibb Recent Development
• 10.10 Johnson
  • 10.10.1 Johnson Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Anti-Infective Drugs
  • 10.10.4 Anti-Infective Drugs Product Introduction
  • 10.10.5 Johnson Recent Development
• 10.11 Roche Pharma AG
• 10.12 Nanosphere
• 10.13 NanoViricides
• 10.14 Novabay Pharmaceuticals
• 10.15 Obetech
• 10.16 Optimer Pharmaceuticals
• 10.17 Basilea Pharmaceutica AG
• 10.18 Daiichi Sankyo
• 10.19 MerLion Pharma
• 10.20 Theravance

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Anti-Infective Drugs Sales Channels
  • 11.2.2 Anti-Infective Drugs Distributors
• 11.3 Anti-Infective Drugs Customers

12 Market Forecast

• 12.1 Global Anti-Infective Drugs Sales and Revenue Forecast 2019-2025
• 12.2 Global Anti-Infective Drugs Sales Forecast by Type
• 12.3 Global Anti-Infective Drugs Sales Forecast by Application
• 12.4 Anti-Infective Drugs Forecast by Regions
  • 12.4.1 Global Anti-Infective Drugs Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Anti-Infective Drugs Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
In 2019, the market size of Anti-Infective Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti-Infective Drugs.

This report studies the global market size of Anti-Infective Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti-Infective Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Wyeth
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
MerLion Pharma
Theravance

Market Segment by Product Type
OTC
Rx Drugs

Market Segment by Application
Hospital
Drugs Store
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Anti-Infective Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti-Infective Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Anti-Infective Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025